Reviva Pharmaceuticals Holdings, Inc. ( RVPH) - Key Metrics
RVPH Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$185,315.39 | -$447,929 | -$447,929 |
| 2026Q1 | $0 | -$0.46 | -$0.54 | -$0.54 |
| 2025Q4 | $0 | -$0.93 | -$1.60 | -$1.60 |
| 2025Q3 | $0 | -$1.10 | -$1.54 | -$1.54 |
| 2025Q2 | $0 | -$2.43 | -$2.01 | -$2.01 |
RVPH Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.83 |
| 2026Q1 | 0% | -0.40 |
| 2025Q4 | 0% | -0.27 |
| 2025Q3 | 0% | -1.67 |
| 2025Q2 | 0% | -0.79 |
RVPH
Price: $0.48
52 week price:
Earnings Per Share: -1.03 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 71600
Market Capitalization: 6.4 million